Bunnell, United States
Beutlich® Pharmaceuticals, LLC has been offering dental professionals unique solutions for pain management and preventative care since 1954. They are best known for their family of HurriCaine® Topical Anesthetics containing 20% Benzocaine. Since Beutlich introduced HurriCaine into dentistry, dentists around the world have built better practices by easing their patients’ pain. HurriCaine was the first of its kind and remains the highest quality choice in the dental marketplace.
The company operates in the Biopharma, Health Care, Manufacturing, and Pharmaceutical industries, providing crucial solutions and products to address pain management and preventive care.
Although the last investment information and investors are not currently available, Beutlich Pharmaceuticals is a well-established company with a long history of providing innovative solutions and products to the dental industry.
